207 related articles for article (PubMed ID: 8996203)
1. Ca++ sensitizers impair cardiac relaxation in failing human myocardium.
Hajjar RJ; Schmidt U; Helm P; Gwathmey JK
J Pharmacol Exp Ther; 1997 Jan; 280(1):247-54. PubMed ID: 8996203
[TBL] [Abstract][Full Text] [Related]
2. Different effect of the Ca(2+) sensitizers EMD 57033 and CGP 48506 on cross-bridge cycling in human myocardium.
Brixius K; Mehlhorn U; Bloch W; Schwinger RH
J Pharmacol Exp Ther; 2000 Dec; 295(3):1284-90. PubMed ID: 11082466
[TBL] [Abstract][Full Text] [Related]
3. EMD 53998 acts as Ca(2+)-sensitizer and phosphodiesterase III-inhibitor in human myocardium.
Uhlmann R; Schwinger RH; Lues I; Erdmann E
Basic Res Cardiol; 1995; 90(5):365-71. PubMed ID: 8585857
[TBL] [Abstract][Full Text] [Related]
4. Effects of calcium sensitizers on intracellular calcium handling and myocardial energetics.
Hasenfuss G; Pieske B; Kretschmann B; Holubarsch C; Alpert NR; Just H
J Cardiovasc Pharmacol; 1995; 26 Suppl 1():S45-51. PubMed ID: 8907130
[TBL] [Abstract][Full Text] [Related]
5. Effects of Ca2+ sensitizers on contraction, [Ca2+]i transient and myofilament Ca2+ sensitivity in diabetic rat myocardium: potential usefulness as inotropic agents.
Ishitani T; Hattori Y; Sakuraya F; Onozuka H; Makino T; Matsuda N; Gando S; Kemmotsu O
J Pharmacol Exp Ther; 2001 Aug; 298(2):613-22. PubMed ID: 11454923
[TBL] [Abstract][Full Text] [Related]
6. Reduced stretch-induced force response in failing human myocardium caused by impaired Na(+)-contraction coupling.
von Lewinski D; Kockskämper J; Zhu D; Post H; Elgner A; Pieske B
Circ Heart Fail; 2009 Jan; 2(1):47-55. PubMed ID: 19808315
[TBL] [Abstract][Full Text] [Related]
7. Effects of the Ca2+ sensitizers EMD 57033 and CGP 48506 on myocardial contractility and Ca2+ transients in human ventricular and atrial myocardium.
Brixius K; Reicke S; Reuter H; Schwinger RH
Z Kardiol; 2002 Apr; 91(4):312-8. PubMed ID: 12063703
[TBL] [Abstract][Full Text] [Related]
8. Effect of cyclopiazonic acid on the force-frequency relationship in human nonfailing myocardium.
Schwinger RH; Brixius K; Bavendiek U; Hoischen S; Müller-Ehmsen J; Bölck B; Erdmann E
J Pharmacol Exp Ther; 1997 Oct; 283(1):286-92. PubMed ID: 9336335
[TBL] [Abstract][Full Text] [Related]
9. Ranolazine improves diastolic dysfunction in isolated myocardium from failing human hearts--role of late sodium current and intracellular ion accumulation.
Sossalla S; Wagner S; Rasenack EC; Ruff H; Weber SL; Schöndube FA; Tirilomis T; Tenderich G; Hasenfuss G; Belardinelli L; Maier LS
J Mol Cell Cardiol; 2008 Jul; 45(1):32-43. PubMed ID: 18439620
[TBL] [Abstract][Full Text] [Related]
10. Cardiovascular profile of the calcium sensitizer EMD 57033 in open-chest anaesthetized pigs with regionally stunned myocardium.
de Zeeuw S; Trines SA; Krams R; Verdouw PD; Duncker DJ
Br J Pharmacol; 2000 Apr; 129(7):1413-22. PubMed ID: 10742297
[TBL] [Abstract][Full Text] [Related]
11. Enantioselective inotropic actions of the Na+-channel activators BDF 9148, BDF 9196 and BDF 9167 in human failing and nonfailing myocardium.
Schwinger RH; Müller-Ehmsen J; Böhm M; Erdmann E
J Pharmacol Exp Ther; 1996 Mar; 276(3):1180-8. PubMed ID: 8786551
[TBL] [Abstract][Full Text] [Related]
12. Inotropic effect of the cardioprotective agent 2,3-butanedione monoxime in failing and nonfailing human myocardium.
Schwinger RH; Böhm M; Koch A; Morano I; Rüegg JC; Erdmann E
J Pharmacol Exp Ther; 1994 May; 269(2):778-86. PubMed ID: 8182546
[TBL] [Abstract][Full Text] [Related]
13. [New cardiotonic/inodilator agents: energetic aspects].
Hasenfuss G
Z Kardiol; 1992; 81 Suppl 4():57-63. PubMed ID: 1290307
[TBL] [Abstract][Full Text] [Related]
14. Improved mechanoenergetics and cardiac rest and reserve function of in vivo failing heart by calcium sensitizer EMD-57033.
Senzaki H; Isoda T; Paolocci N; Ekelund U; Hare JM; Kass DA
Circulation; 2000 Mar; 101(9):1040-8. PubMed ID: 10704173
[TBL] [Abstract][Full Text] [Related]
15. Contribution of abnormal sarcoplasmic reticulum ATPase activity to systolic and diastolic dysfunction in human heart failure.
Schmidt U; Hajjar RJ; Helm PA; Kim CS; Doye AA; Gwathmey JK
J Mol Cell Cardiol; 1998 Oct; 30(10):1929-37. PubMed ID: 9799647
[TBL] [Abstract][Full Text] [Related]
16. A new cardiotonic drug reduces the energy cost of active tension in cardiac muscle.
Gross T; Lues I; Daut J
J Mol Cell Cardiol; 1993 Mar; 25(3):239-44. PubMed ID: 8510167
[TBL] [Abstract][Full Text] [Related]
17. Effects of cantharidin on force of contraction and phosphatase activity in nonfailing and failing human hearts.
Linck B; Boknik P; Knapp J; Müller FU; Neumann J; Schmitz W; Vahlensieck U
Br J Pharmacol; 1996 Oct; 119(3):545-50. PubMed ID: 8894176
[TBL] [Abstract][Full Text] [Related]
18. Effects of the Ca2+ sensitizer EMD 57033 on intracellular Ca2+ in rat ventricular myocytes: relevance to arrhythmogenesis during positive inotropy.
Kawai M; Lee JA; Orchard CH
Clin Sci (Lond); 2000 Dec; 99(6):547-54. PubMed ID: 11099399
[TBL] [Abstract][Full Text] [Related]
19. Cardiac inotropic as well as coronary and pulmonary artery actions of epinine in human isolated tissues.
Schwinger RH; Böhm M; Schulz C; Schmidt U; Schmidt U; Schmid B; Dienemann H; Reichart B; Erdmann E
J Pharmacol Exp Ther; 1993 Apr; 265(1):346-57. PubMed ID: 8386240
[TBL] [Abstract][Full Text] [Related]
20. Comparison between the effects of a novel Ca++ sensitizer and a phosphodiesterase inhibitor on stunned myocardium.
Korbmacher B; Sunderdiek U; Schulte HD; Arnold G; Schipke JD
J Pharmacol Exp Ther; 1995 Dec; 275(3):1433-41. PubMed ID: 8531113
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
